• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.

广告
作者: Nadilly,Bonagas [1] ; Nina M S,Gustafsson [1] ; Martin,Henriksson [1] ; Petra,Marttila [1] ; Robert,Gustafsson [2] ; Elisée,Wiita [1] ; Sanjay,Borhade [1] ; Alanna C,Green [3] ; Karl S A,Vallin [1] ; Antonio,Sarno [4] ; Richard,Svensson [5] ; Camilla,Göktürk [1] ; Therese,Pham [1] ; Ann-Sofie,Jemth [1] ; Olga,Loseva [1] ; Victoria,Cookson [3] ; Nicole,Kiweler [6] ; Lars,Sandberg [7] ; Azita,Rasti [1] ; Judith E,Unterlass [1] ; Martin,Haraldsson [8] ; Yasmin,Andersson [9] ; Emma R,Scaletti [10] ; Christoffer,Bengtsson [7] ; Cynthia B J,Paulin [1] ; Kumar,Sanjiv [1] ; Eldar,Abdurakhmanov [11] ; Linda,Pudelko [1] ; Ben,Kunz [1] ; Matthieu,Desroses [1] ; Petar,Iliev [1] ; Katarina,Färnegårdh [7] ; Andreas,Krämer [12] ; Neeraj,Garg [13] ; Maurice,Michel [1] ; Sara,Häggblad [14] ; Malin,Jarvius [15] ; Christina,Kalderén [1] ; Amanda Bögedahl,Jensen [1] ; Ingrid,Almlöf [1] ; Stella,Karsten [1] ; Si Min,Zhang [1] ; Maria,Häggblad [14] ; Anders,Eriksson [16] ; Jianping,Liu [16] ; Björn,Glinghammar [8] ; Natalia,Nekhotiaeva [16] ; Fredrik,Klingegård [7] ; Tobias,Koolmeister [1] ; Ulf,Martens [14] ; Sabin,Llona-Minguez [1] ; Ruth,Moulson [1] ; Helena,Nordström [11] ; Vendela,Parrow [15] ; Leif,Dahllund [9] ; Birger,Sjöberg [8] ; Irene L,Vargas [1] ; Duy Duc,Vo [13] ; Johan,Wannberg [13] ; Stefan,Knapp [12] ; Hans E,Krokan [4] ; Per I,Arvidsson [8] ; Martin,Scobie [1] ; Johannes,Meiser [6] ; Pål,Stenmark [10] ; Ulrika Warpman,Berglund [1] ; Evert J,Homan [1] ; Thomas,Helleday [17]
作者单位: Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden. [1] Department of Biochemistry & Biophysics, Stockholm University, Stockholm, Sweden. [2] Weston Park Cancer Centre, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK. [3] Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. [4] Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, Uppsala, Sweden. [5] Cancer Metabolism Group, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg. [6] Drug Discovery and Development Platform, Science for Life Laboratory, Department of Organic Chemistry, Stockholm University, Solna, Sweden. [7] Drug Discovery and Development Platform, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden. [8] Drug Discovery and Development Platform, Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology, Solna, Sweden. [9] Department of Biochemistry & Biophysics, Stockholm University, Stockholm, Sweden.;Department of Experimental Medical Science, Lund University, Lund, Sweden. [10] Drug Discovery and Development Platform, Science for Life Laboratory, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden. [11] Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany. [12] Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. [13] Biochemical and Cellular Screening Facility, Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden. [14] Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden. [15] Karolinska High Throughput Centre, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden. [16] Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden. thomas.helleday@scilifelab.se.;Weston Park Cancer Centre, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK. thomas.helleday@scilifelab.se. [17]
DOI 10.1038/s43018-022-00331-y
PMID 35228749
发布时间 2024-08-24
提交
  • 浏览2
Nature cancer

Nature cancer

2022年3卷2期

156-172页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷